Conclusions. The relative lack of an objective definition of myocardial ischemia and the marked variability of use of procedures according to geographic region suggest the need for further implementation of established guidelines. (Circulation 1993; 87:1489 -1497 KEY WoRDs * angioplasty * cost analysis * sex * geographic region C oronary revascularization with balloon angioplasty was first introduced in the United States in 1978; within 12 years, there has been such remarkable growth in the use of this technique that over 300,000 procedures were performed in 1990.1,2 Balloon dilatation is successful in 85-90% of patients for improving the coronary arterial luminal caliber but is limited by abrupt vessel closure in the periprocedural phase and restenosis during 6-month follow-up. 3 In a recent randomized trial for patients with one-vessel coronary artery disease, angioplasty compared favorably with medical therapy for improvement of exercise capacity. 4 For multivessel disease, several randomized trials of angioplasty versus bypass surgery are presently under way, but results of these studies will not be available for at least 2-3 years. 5 In the meantime, the American Heart Association and the American College of Cardiology have published guidelines for the use of coronary angioplasty.6 For example, in patients with stable angina, the guidelines state that for angioplasty to be performed, there must be "objective evidence of myocardial ischemia while on medical therapy during See p 1749 laboratory testing."6 Whether such guidelines have been generally adopted remains unclear. The purpose of the present study was to describe angioplasty practice patterns in the United States. To date, no such studies have been completed. Using a large private insurance claims data base, we focused on indications for angioplasty procedures, specifically whether an exercise test preceded the angioplasty, geographic variability in angioplasty practice, sex differences, the effect of training programs, and associated charges.
Methods

Data Base and Patient Population
For this study, we used a data base (MEDSTAT Systems, Ann Arbor, Mich.) comprising all the health Tables 4 and 5 ).
Angioplasty Practice by Geographic Region
The Midwest accounted for 34% of the overall MEDSTAT data base population but 48% of the angioplasty cohort (Table 6 ). The relative proportion of patients for the other regions in this angioplasty cohort and overall data base are for the Northeast, 19% and 12%, respectively; for the South, 30% and 24%, respectively; and for the West, 17% and 16%, respectively. There were no differences in key baseline demographic characteristics, such as age and sex, or by geographic region in the overall population. Along with this preponderance of angioplasty procedures in the Midwest, the use of exercise testing tended to be lower in this region than in two of the other regions.
Patients in the Northeast had the longest hospitalization stays but among the least in total charges. By multiple regression analysis for length of stay, the Northeast was significantly associated with an increased duration, whereas the Midwest and the West were associated with a decreased length of stay ( Table 4 ). The use of subsequent bypass surgery was highest in the West. As described in the legend in Figure 1 , this region was associated with an increased use of bypass surgery. In addition, the western region was significantly associated with increased index hospital and professional charges (Table 6 ).
Sex Differences
Women in the angioplasty cohort tended to be older, less likely to have myocardial infarction or unstable angina, and to have an increased length of hospital stay and higher charges compared with men ( Table 7) . As shown in Table 2 , female sex was associated with lack of an exercise test before angioplasty. Female sex also proved to be significantly associated with increased hospital stay and higher charges by multiple regression analysis (Tables 4 and 5 ). Factors Associated With Clinical Outcomes Figure 1 shows the Kaplan-Meier survival curve computed for each of the clinical outcomes. The associates of each of the outcome variables were assessed via multivariable log-rank procedures and are described below and summarized in the legends to Figure 1 There was substantial geographic variability in angioplasty practice throughout the United States. It was ironic to find that the region with the greatest length of stay was among those with the lowest cumulative charges. Although the western region charges were the highest, this patient group was most likely to have exercise testing before the procedure and had the shortest hospital stay. The lack of concordance between regions for such important indexes as preprocedural screening, length of stay, use and type of subsequent coronary revascularization procedures, and charges indicates that considerable variance exists in how the procedure is currently practiced and a lack of standardization. Similar findings from a Medicare data base have been published for coronary artery bypass surgery. 21, 22 Although only 8% of the procedures in the angioplasty data base were performed in institutions with cardiovascular training programs, their impact was noteworthy. Not only was there an increased likelihood of exercise testing before the procedure, but patients treated in these centers had a relatively short hospital stay and reduced charges. In many hospitals with cardiology training programs, patients with uncomplicated coronary angioplasty are admitted to the hospital the day of the procedure and discharged within 24 hours. For improvement in the cost-effectiveness of coronary angioplasty, a regional approach involving cardiovascular training programs appears to deserve further study.
This analysis of contemporary coronary angioplasty practice in the United States has been instructive in that it highlights the large proportion of patients without objective definition of myocardial ischemia undergoing the procedure and points out variability in practice with respect to patient sex as well as the geographic location and academic status of hospital sites. With more than $8 billion of health care charges per year for coronary angioplasty procedures in this country, it behooves us to carefully scrutinize selection criteria, procedural and long-term outcomes, and key economic parameters. Although coronary angioplasty represents one of the most significant advances in cardiovascular medicine in the 1980s, it will be important to implement more effective use in the present decade.
